FDA Inspection
Acadia Pharmaceuticals Inc.Acadia Pharmaceuticals Inc. – FDA Inspection, Feb 17, 2016
Record Details
This FDA Inspection record concerns Acadia Pharmaceuticals Inc., with an inspection on February 17, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Acadia Pharmaceuticals Inc.
- Inspection Date
- February 17, 2016
- Product Type
- Drugs
View Company Profile
ID · a5ee1d2d-f85e-40e7-a860-6147f71960c4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 965150
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 312.56(a)Monitoring investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Acadia Pharmaceuticals Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 27, 2021 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Acadia Pharmaceuticals Inc.
- FDA Inspection 1135361 - 2021-01-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.